These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35638109)

  • 1. DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m
    Shen W; Zhu M; Wang Q; Zhou X; Wang J; Wang T; Zhang J
    RNA Biol; 2022 Jan; 19(1):751-763. PubMed ID: 35638109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DARS-AS1 accelerates the proliferation of cervical cancer cells via miR-628-5p/JAG1 axis to activate Notch pathway.
    Chen Y; Wu Q; Lin J; Wei J
    Cancer Cell Int; 2020 Nov; 20(1):535. PubMed ID: 33292218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p.
    Zhu J; Han S
    Technol Cancer Res Treat; 2020; 19():1533033820971669. PubMed ID: 33176595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway.
    Kong X; Wang JS; Yang H
    J Biochem Mol Toxicol; 2021 Jun; 35(6):1-11. PubMed ID: 33634536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
    Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
    Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3's role in cervical cancer development through m
    Liu Y; Li C; Deng Q; Ren X; Wang H
    FASEB J; 2024 Jun; 38(11):e23693. PubMed ID: 38809685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DARS-AS1: A Vital Oncogenic LncRNA Regulator with Potential for Cancer Prognosis and Therapy.
    Shu J; Xia K; Luo H; Wang Y
    Int J Med Sci; 2024; 21(3):571-582. PubMed ID: 38322590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3/METTL14 Transactivation and m
    Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Long Noncoding RNA DARS-AS1 in Childhood Acute Myeloid Leukemia by Binding to microRNA-425.
    Dou B; Jiang Z; Chen X; Wang C; Wu J; An J; Sheng G
    Technol Cancer Res Treat; 2020; 19():1533033820965580. PubMed ID: 33073700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of LncRNA DARS-AS1 Inhibits the Tumorigenesis of Cervical Cancer via Inhibition of IGF2BP3.
    Zhu J; Han S
    Onco Targets Ther; 2021; 14():1331-1340. PubMed ID: 33658798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer.
    Huang K; Fan WS; Fu XY; Li YL; Meng YG
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2353-2359. PubMed ID: 30964159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyltransferase-like 3 induces the development of cervical cancer by enhancing insulin-like growth factor 2 mRNA-binding proteins 3-mediated apoptotic chromatin condensation inducer 1 mRNA stability.
    Su C; Zhang Y; Chen P; Yang W; Du J; Zhang D
    Bioengineered; 2022 Mar; 13(3):7034-7048. PubMed ID: 35255776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 17. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
    Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
    Yang J; Liang B; Hou S
    J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
    Jiao M; Guo H; Chen Y; Li L; Zhang L
    Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    Chen S; Li K
    BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.